Showing results (1981-1990 of 2,029) with videos related to

Sort By:
Pageof 203
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Immunity|October 14, 2014
Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cellsVanessa M Hubbard-Lucey, Yusuke Shono, Katie Maurer, et al.
The Science of the Total Environment|January 14, 2023
Long-term trends in crayfish invasions across European riversIsmael Soto, Danish A Ahmed, Ayah Beidas, et al.
Cytotherapy|October 4, 2020
Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human dataAndreas Kerstan, Elke Niebergall-Roth, Jasmina Esterlechner, et al.
Cancer Research|June 5, 2013
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHDArnab Ghosh, Amanda M Holland, Yildirim Dogan, et al.
The New England Journal of Medicine|May 10, 2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancersSimon J Stanworth, Lise J Estcourt, Gillian Powter, et al.
Cancer Immunology Research|May 20, 2014
Bevacizumab plus ipilimumab in patients with metastatic melanomaF Stephen Hodi, Donald Lawrence, Cecilia Lezcano, et al.
Cell Reports|September 1, 2015
ABCB5 Identifies Immunoregulatory Dermal CellsTobias Schatton, Jun Yang, Sonja Kleffel, et al.
JAMA|March 13, 2019
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus ConferenceMarkus M Mueller, Hans Van Remoortel, Patrick Meybohm, et al.
Blood|November 2, 2018
Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in miceJennifer J Tsai, Enrico Velardi, Yusuke Shono, et al.
Pageof 203